-
Mashup Score: 3QALY-fying the value of life - 9 month(s) ago
Questions about the ethics of QALYs
Source: rafaelfonseca.substack.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy - 9 month(s) ago
Radiation therapy (RT) may play an important role prior to and following BCMA-targeted CAR T-cell therapy in multiple myeloma (MM). We report a series…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet-
Another very small study showed perhaps improved outcomes in those using bridging radiation. Again, way too small to draw any conclusions. https://t.co/57uc0V6oN9 9/x https://t.co/YCSmGo3feJ
-
-
Mashup Score: 45
Read it now on PracticeUpdate.com
Source: www.practiceupdate.comCategories: General Medicine News, Hem/OncsTweet-
Genomic Classification and Individualized Prognosis in Multiple Myeloma | comment: Rafael Fonseca MD https://t.co/QL5sjFM3pA via @practiceupdate
-
-
Mashup Score: 40Genomic Classification and Individualized Prognosis in Multiple Myeloma - 10 month(s) ago
Read it now on PracticeUpdate.com
Source: www.practiceupdate.comCategories: General Medicine News, Hem/OncsTweet-
Genomic Classification and Individualized Prognosis in Multiple Myeloma | comment: Rafael Fonseca MD https://t.co/QL5sjFM3pA via @practiceupdate
-
-
Mashup Score: 6Incidence or T cell lymphoma in patients diagnosed with multiple myeloma or diffuse large B-cell lymphoma - 10 month(s) ago
A Komodo Real World Evidence analysis
Source: rafaelfonseca.substack.comCategories: General Medicine News, Hem/OncsTweet-
These data is presented in greater detail in this Substack with the primary author being Dr @GKaurMD and the other authors are @ARosenthalDO, @erivaserra and @Chhabra_mayo https://t.co/RFgJAWhb0U 8/xl #mmSM #lymSM
-
-
Mashup Score: 6Incidence or T cell lymphoma in patients diagnosed with multiple myeloma or diffuse large B-cell lymphoma - 10 month(s) ago
A Komodo Real World Evidence analysis
Source: rafaelfonseca.substack.comCategories: General Medicine News, Hem/OncsTweet-
These data is presented in greater detail in this Substack with the primary author being Dr @GKaurMD and the other authors are @ARosenthalDO, @erivaserra and @Chhabra_mayo https://t.co/RFgJAWhb0U 8/xl #mmSM #lymSM
-
-
Mashup Score: 6Incidence or T cell lymphoma in patients diagnosed with multiple myeloma or diffuse large B-cell lymphoma - 10 month(s) ago
A Komodo Real World Evidence analysis
Source: rafaelfonseca.substack.comCategories: General Medicine News, Hem/OncsTweet-
These data is presented in greater detail in this Substack with the primary author being Dr @GKaurMD and the other authors are @ARosenthalDO, @erivaserra and @Chhabra_mayo https://t.co/RFgJAWhb0U 8/xl #mmSM #lymSM
-
-
Mashup Score: 1Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid Arthritis - 10 month(s) ago
To explore the clinical efficacy and safety of generic tofacitinib vs brand name tofacitinib in patients with rheumatoid arthritis (RA) in a single-ce…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet-
Excellent news - as should be. Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid Arthritis https://t.co/LTH82fPX1O
-
-
Mashup Score: 0Argentina Is One of the Most Regulated Countries in the World - 11 month(s) ago
In the coming days and weeks, we can expect further, far‐reaching reform proposals that will go through the Argentine congress.
Source: www.cato.orgCategories: General Medicine News, Hem/OncsTweet-
Argentina Is One of the Most Regulated Countries in the World https://t.co/3t7ZSrbt5I via @CatoInstitute
-
-
Mashup Score: 46ASH 2023 login - 11 month(s) ago
This site is intended for attendees of the congress where the research is presented and limited to healthcare professionals. This site contains scientific presentations on investigational products and/or investigational uses of approved products for Janssen-sponsored studies. Some studies sponsored by Janssen’s research …
Source: www.congresshub.comCategories: General Medicine News, Hem/OncsTweet-
Interesting tidbits after ASH. Looking at the effectiveness of therapy after talquetamab in patients enrolled in the MonumenTAL-1 Phase 1/2 study. BOTTOM LINE: Usual therapies in advanced MM are not very effective. https://t.co/GV9YoQmvRd #ASCO23RF #mmsm https://t.co/In3YQS2vlw
-
I just heard about a vote tomorrow aiming to extend the prohibition of quality-adjusted life years (QALY) that devalues lives based on age or disability. I thought to repost my write-up from 2016. https://t.co/HLWYovuErM @HouseCommerce @cathymcmorris @oncotastic #QALY… https://t.co/jRmSeoZLb1 https://t.co/MrclJOeES0